Why Right Now Could Be a Great Time to Buy Moderna Stock
Shoulda, woulda, coulda. That's likely what some investors are thinking with respect to Moderna (NASDAQ: MRNA). The company's initial public offering in 2018 was the biggest in biotech history. A year earlier, Moderna had been named to CNBC's list of the 50 top disruptors among private companies. There have been some pretty good signs that the biotech could be a big winner.
And winning is exactly what Moderna has done this year. It's become one of the most talked-about companies thanks to its progress in developing a COVID-19 vaccine candidate. The biotech stock has more than quadrupled.
Despite this huge gain, though, it might not be too late to buy Moderna. In fact, right now could be a great time to buy the stock for one key reason.
Source Fool.com
